Dow Pharm Company Profile

✉ Email this page to a colleague

DOW PHARM has nine approved drugs.

There are two US patents protecting DOW PHARM drugs.

There are seven patent family members on DOW PHARM drugs in eight countries and eighteen supplementary protection certificates in thirteen countries.

International Patents:	7
US Patents:	2
Tradenames:	7
Ingredients:	7
NDAs:	9
Patent Litigation for Dow Pharm:	See patent lawsuits for Dow Pharm

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Dow Pharm	QUIDE	piperacetazine	TABLET;ORAL	013615-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Dow Pharm	NUTRACORT	hydrocortisone	LOTION;TOPICAL	080443-002	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Dow Pharm	SANSAC	erythromycin	SOLUTION;TOPICAL	062522-001	Jan 24, 1985		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Dow Pharm	NUTRACORT	hydrocortisone	LOTION;TOPICAL	087644-001	Aug 24, 1982		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Dow Pharm	ALTRENO	tretinoin	LOTION;TOPICAL	209353-001	Aug 23, 2018		RX	Yes	Yes	10,653,656	⤷ Sign Up	Y			⤷ Sign Up
Dow Pharm	QUIDE	piperacetazine	TABLET;ORAL	013615-002	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Dow Pharm	DOW-ISONIAZID	isoniazid	TABLET;ORAL	080330-002	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Dow Pharm	ATRALIN	tretinoin	GEL;TOPICAL	022070-001	Jul 26, 2007	5,670,547	⤷ Sign Up
Dow Pharm	ALTRENO	tretinoin	LOTION;TOPICAL	209353-001	Aug 23, 2018	6,517,847	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration
European Patent Office	3773641	⤷ Sign Up
Poland	3773641	⤷ Sign Up
Brazil	112020020431	⤷ Sign Up
World Intellectual Property Organization (WIPO)	2019195697	⤷ Sign Up
Canada	3095937	⤷ Sign Up
Argentina	114730	⤷ Sign Up
Spain	2974819	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration

Subscribe to access the full database, or Sign Up
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1304992	2013/044	Ireland	⤷ Sign Up	PRODUCT NAME: CLINDAMYCIN AND TRETINOIN; REGISTRATION NO/DATE: PA1332/043/001 20130322
1304992	SPC/GB13/061	United Kingdom	⤷ Sign Up	PRODUCT NAME: CLINDAMYCIN PHOSPHATE IN COMBINATION WITH TRETINOIN.; REGISTERED: IE PA1332/043/001 20130322; UK PL15142/0249 20130624
1304992	132013902214376	Italy	⤷ Sign Up	PRODUCT NAME: CLINDAMICINA FOSFATO E TRETINOINA(ACNATAC); AUTHORISATION NUMBER(S) AND DATE(S): PA1332/043/001, 20130322;042056010/M - 022/M, 20130718
0809498	SPC/GB10/012	United Kingdom	⤷ Sign Up	PRODUCT NAME: A COMBINATION OF ACYCLOVIR AND HYDROCORTISONE; REGISTERED: UK PL18191/0001-0001 20091112
1304992	2013C/060	Belgium	⤷ Sign Up	PRODUCT NAME: CLINDAMYCINE (ALS CLINDAMYCINE FOSFAAT) EN TRETINOINE; AUTHORISATION NUMBER AND DATE: BE437507 20130506
0617614	11/2001	Austria	⤷ Sign Up	PRODUCT NAME: ALITRETINOIN; REGISTRATION NO/DATE: EU/1/00/149/001 20001011
1304992	CR 2013 00053	Denmark	⤷ Sign Up	PRODUCT NAME: CLINDAMYCIN (SOM CLINDAMYCIN PHOSPHATE) OG TRETINOIN; NAT. REG. NO/DATE: 48954 20130416; FIRST REG. NO/DATE: IE PA1332/043/001 20130322
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.